ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,063Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 1290

$651K Total Retail Price of All Prescriptions

Rank: 122 out of 1290

378 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 378 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 378 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 9,129 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 427 393 1 4
FUROSEMIDE 327 324 2 9
SIMVASTATIN 294 273 3 1
AMLODIPINE BESYLATE 265 252 4 3
METOPROLOL TARTRATE 236 228 5 7
POTASSIUM CHLORIDE 209 195 6 35
TRAMADOL HCL 183 173 7 25
HYDROCODONE-ACETAMINOPHEN 177 168 S3 8 6
LISINOPRIL 172 160 9 5
WARFARIN SODIUM 153 147 10 22
CRESTOR 146 133 11 17
METOPROLOL SUCCINATE 141 125 12 14
LOSARTAN POTASSIUM 132 125 13 19
NAMENDA 131 131 14 27
ATENOLOL 131 127 14 18
OMEPRAZOLE 125 100 16 2
IPRATROPIUM-ALBUTEROL 124 120 17 368
DONEPEZIL HCL 121 121 18 13
ESCITALOPRAM OXALATE 109 109 19 63
GABAPENTIN 108 95 20 8
METFORMIN HCL 104 82 21 10
ATORVASTATIN CALCIUM 103 101 22 23
ZOLPIDEM TARTRATE 102 98 23 15
CYMBALTA 98 75 24 59
PRAVASTATIN SODIUM 98 94 24 42
CARVEDILOL 95 92 26 12
HYDROCHLOROTHIAZIDE 95 91 26 20
CITALOPRAM HBR 95 83 26 29
SERTRALINE HCL 80 70 29 36
CLOPIDOGREL 80 78 29 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 65 31 92
LYRICA 75 42 32 94
PREDNISONE 74 73 33 21
CARBIDOPA-LEVODOPA 73 73 34 43
LIDODERM 72 61 35 113
TAMSULOSIN HCL 68 65 36 11
LANTUS 65 65 37 67
FENTANYL 65 57 S2 37 89
FLUTICASONE PROPIONATE 64 43 39 26
MIRTAZAPINE 61 61 40 93
DIOVAN HCT 60 55 41 112
DIGOXIN 60 60 41 51
TRAZODONE HCL 60 55 41 44
SPIRIVA 59 57 44 75
QUETIAPINE FUMARATE 56 51 45 80
ALBUTEROL SULFATE 56 46 45 319
LEXAPRO 55 54 47 173
FAMOTIDINE 55 55 47 128
SPIRONOLACTONE 54 51 49 126
NYSTOP 54 54 49 481
LATANOPROST 53 53 51 16
DIOVAN 52 52 52 53
MORPHINE SULFATE 50 46 S2 53 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 23, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.